Thomas Monica R. 4
4 · G1 Therapeutics, Inc. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
Thomas Monica R.
General Counsel
Transactions
- Award
Stock Options (Right to Buy)
2024-01-03+55,875→ 55,875 totalExercise: $2.97Exp: 2034-01-03→ Common Stock (55,875 underlying) - Award
Common Stock
2024-01-03+27,975→ 78,151 total
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award that vests 25% on January 3, 2025 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 176 shares of common stock; (ii) 50,000 RSUs from award granted on May 22, 2023; and (iii) 27,975 RSUs from award granted on January 3, 2024.
- [F4]The shares underlying this option vest as to 25% of the shares on January 3, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.